Congenital craniopharyngioma and hypercalcemia induced by parathyroid hormone-related protein

Endocrine Practice

Volumn 13, Issue 1, 2007, Pages 67-71

  Brown, Jessica L ^a   Burton, Douglas W ^b   Deftos, Leonard J ^b   Smith, Amy A ^a   Pincus, David W ^a   Haller, Michael J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE RELATED PROTEIN;

ADULT; ARTICLE; BLOOD; CASE REPORT; CRANIOPHARYNGIOMA; FATALITY; FEMALE; HUMAN; HYPERCALCEMIA; HYPOPHYSIS TUMOR; METABOLISM; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREGNANCY; PRENATAL DIAGNOSIS;

ADULT; CALCIUM; CRANIOPHARYNGIOMA; FATAL OUTCOME; FEMALE; HUMANS; HYPERCALCEMIA; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; PARATHYROID HORMONE-RELATED PROTEIN; PITUITARY NEOPLASMS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 34147135115     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.13.1.67     Document Type: Article

References (32)

1. Choux M, Lena G, Genitori L. Craniopharyngioma in children [article in French]. Neurochirurgie. 1991;37 (Suppl 1):1-174.
2. Bailey W, Freidenberg GR, James HE, Hesselink JR, Jones KL. Prenatal diagnosis of a craniopharyngioma using ultrasonography and magnetic resonance imaging. Prenat Diagn. 1990;10:623-629.
3. Freeman TB, Abati AD, Topsis J, Snyder JR, Beneck D, Lehman LB. Neonatal craniopharyngioma. N Y State J Med. 1988;88:81-83.
4. Kultursay N, Gelal F, Mutluer S, Senrecper S, Oziz E, Oral R. Antenatally diagnosed neonatal craniopharyngioma. J Perinatol. 1995;15:426-428.
5. Snyder JR, Lustig-Gillman I, Milio L, Morris M, Pardes JG, Young BK. Antenatal ultrasound diagnosis of an intracranial neoplasm (craniopharyngioma). J Clin Ultrasound. 1986;14:304-306.
6. Subramani Iyer CB. Case report of an adamantinoma present at birth. J Neurosurg. 1952;9:221-228.
7. Arai T, Ohno K, Takada Y, Aoyagi M, Hirakawa K. Neonatal craniopharyngioma and inference of tumor inception time: case report and review of the literature [with discussion]. Surg Neurol. 2003;60:254-259.
8. Cheddadi D, Triki S, Gallet S, et al. Neonatal rhinopharyngeal obstruction due to craniopharyngioma [article in French]. Arch Pediatr. 1996;3:348-351.
9. Helmke K, Hausdorf G, Moehrs D, Laas R. CCT and sonographic findings in congenital craniopharyngioma. Neuroradiology. 1984;26:523-526.
10. Hurst RW, McIlhenny J, Park TS, Thomas WO. Neonatal craniopharyngioma: CT and ultrasonographic features. J Comput Assist Tomogr. 1988;12:858-861.
11. Kolen ER, Horvai A, Perry V, Gupta N. Congenital craniopharyngioma: a role for imaging in the prenatal diagnosis and treatment of an uncommon tumor. Fetal Diagn Ther. 2003;18:270-274.
12. Strewler GJ, Nissenson RA. Hypercalcemia in malignancy. West J Med. 1990;153:635-640.
13. Leblanc A, Caillaud JM, Hartmann O, et al. Hypercalcemia preferentially occurs in unusual forms of childhood non-Hodgkin's lymphoma, rhabdomyosarcoma, and Wilms' tumor: a study of 11 cases. Cancer. 1984;54: 2132-2136.
14. McKay C, Furman WL. Hypercalcemia complicating childhood malignancies. Cancer. 1993;72:256-260.
15. Martin TJ, Grill V. Hypercalcemia in cancer. J Steroid Biochem Mol Biol. 1992;43:123-129.
16. Knecht TP, Behling CA, Burton DW, Glass CK, Deftos LJ. Humoral hypercalcaemia of "benignancy" [letter]. Lancet. 1995;346:711-712.
17. Knecht TP, Behling CA, Burton DW, Glass CK, Deftos LJ. The humoral hypercalcemia of benignancy: a newly appreciated syndrome. Am J Clin Pathol. 1996;105:487-492.
18. Kovacs CS, Kronenberg HM. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev. 1997;18:832-872.
19. Dobnig H, Kainer F, Stepan V, et al. Elevated parathyroid hormone-related peptide levels after human gestation: relationship to changes in bone and mineral metabolism. J Clin Endocrinol Metab. 1995;80:3699-3707.
20. Saxe A, Dean S, Gibson G, Pandian MR, Levy J. Parathyroid hormone and parathyroid hormone-related peptide in venous umbilical cord blood of healthy neonates. J Perinat Med. 1997;25:288-291.
21. Papantoniou NE, Papapetrou PD, Antsaklis AJ, Kontoleon PE, Mesogitis SA, Aravantinos D. Circulating levels of immunoreactive parathyroid hormone-related protein and intact parathyroid hormone in human fetuses and newborns. Eur J Endocrinol. 1996;134: 437-442.
22. Florez JC, Burton DW, Arnell PM, Deftos LJ, Klibanski A. Hypercalcemia and local production of parathyroid hormone-related protein by a perisellar rhabdomyosarcoma after remote pituitary irradiation. Endocr Pract. 2005;11:184-189.
23. Lakhdir F, Lawson D, Schatz DA. Fatal parathyroid hormone-related protein-induced humoral hypercalcemia of malignancy in a 3-month-old infant. Eur J Pediatr. 1994; 153:718-720.
24. Kawasaki H, Takayama J, Nagasaki K, Yamaguchi K, Ohira M. Hypercalcemia in children with rhabdomyosarcoma. J Pediatr Hematol Oncol. 1998;20:327-329.
25. Kounami S, Yoshiyama M, Nakayama K, Hiramatsu C, Aoyagi N, Yoshikawa N. Severe hypercalcemia in a child with acute nonlymphocytic leukemia: the role of parathyroid hormone-related protein and proinflammatory cytokines. Acta Haematol. 2004;112:160-163.
26. Harutsumi M, Akazai A, Kitamura T, et al. A case of acute lymphoblastic leukemia accompanied with the production of parathyroid hormone-related protein. Miner Electrolyte Metab. 1995;21:171-176.
27. Albright F. Case records of Massachusetts General Hospital (case 27401). N Engl J Med. 1941;225:789-796.
28. Moseley JM, Kubota M, Diefenbach-Jagger H, et al. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci U S A. 1987;84:5048-5052.
29. Suva LJ, Winslow GA, Wettenhall RE, et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science. 1987;237: 893-896.
30. Tashjian AH Jr, Voelkel EF, Lloyd W, Derynck R, Winkler ME, Levine L. Actions of growth factors on plasma calcium: epidermal growth factor and human transforming growth factor-alpha cause elevation of plasma calcium in mice. J Clin Invest. 1986;78:1405-1409.
31. Mundy GR, Martin TJ. The hypercalcemia of malignancy: pathogenesis and management. Metabolism. 1982;31: 1247-1277.
32. Ralston SH. The pathogenesis of humoral hypercalcaemia of malignancy. Lancet. 1987;2:1443-1446.